Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography
NCT04505657Completed
- Sponsor
- Aswan University Hospital
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of lidocaine 10% oropharyngeal spray and celecoxib oral solution in procedural pain (3 arms), sponsored by Aswan University Hospital. Primary endpoint: Mean pain score during the procedure at 10 minutes. Started Sep 2020; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spraycelecoxib oral solution
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT04505657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505657.